137
Views
40
CrossRef citations to date
0
Altmetric
Research Article

A Toxicological Review of Polycyclic Aromatic Hydrocarbons

Pages 101-135 | Published online: 27 Sep 2008

References

  • Zedeck M. S. Polycyclic aromatic hydrocarbons. A review. J. Environ. Pathol. Toxicol. 1980; 3: 537–567
  • Potts P. Chirurgical observations relative to the cataract, the polypus of the nose, the cancer of the scrotum, the different kinds of ruptures and mortification of the toes and feet. Hawes, Clarke and Collins, London 1775
  • Yamagiwa K., Ichikawa K. Experimentelle Studie über die Pathogenese der Epithelial-geschwülste. Mitt. Med. Fat Univ. Tokio. 1915; 15: 295–344
  • Dipple A., Moschel R. C., Bigger C. A. H. Polycyclic aromatic carcinogens. In, Chemical carcinogens. Am. Chem. Soc. Monogr. 1984; 182: 41–163
  • Harvey S. C. Antiseptics and disinfectants: fungicides: ectoparasiticides. Goodman and Gil-man's, The Pharmacological Basis of TherapeuticsEditors 7th Ed., A. Goodman Gilman, L. S. Goodman, T. W. Rail, F. Murad, Macmillan 1985
  • Andrews A. W., Thibault L. H., Lijinsky W. The relationship between carcinogenicity and mutagenicity of some polynuclear hydrocarbons. Mutat. Res. 1978; 51: 311–318
  • Walker C. L. Oncogenes and tumor suppressor genes: components in a multistage model of carcinogenesis. CIIT Activities 1989; 9(11–12)1–5
  • Shaw G. R., Connell D. W. Prediction and monitoring of the carcinogenicity of polycyclic aromatic compounds. Rev. Environ. Contamin. Toxicol. 1994; 135: 1–62
  • Dipple A. Polycyclic aromatic hydrocarbon carcinogenesis. An introduction. Polycyclic Hydrocarbons and Carcinogenesis, R. G. Harvey. American Chemical Society, Washington 1985; 1–17
  • Glauert H. P., Schwarz M., Pitot H. C. The phenotypic stability of altered hepatic foci: effect of the short-term withdrawal of phenobarbital and of the long-term feeding of purified diets after the withdrawal of phenobarbital. Carcinogen. 1986; 7: 117–121
  • Pitot H. C. Mechanisms of chemical carcinogenesis: theoretical and experimental bases. Chemical Carcinogenesis and Mutagenesis I. Handbook of Experimental Pharmacology 94/1, C. S. Cooper, P. L. Growler. Springer-Verlag, London 1990; 2–29
  • Takematsu M., Nagamine Y., Faber E. Redifferentiation as a basis for remodelling of carcinogen-induced hepatocyte nodules to normal appearing liver. Cancer Res. 1983; 43: 4049–4058
  • Neumann H. G., Hammerl R., Hillesheim W. Role of genotoxic and nongenotoxic effects in multistage carcinogenicity of aromatic amines. Cancer Res. 1990; 39: 4760–4761
  • Pitot H. C. Fundamentals of Oncology3rd ed. Marcel Dekker, New York 1986
  • Harris C. Future directions in the use of DNA adducts as internal dosimeters for monitoring human exposure to environmental mutagens and carcinogens. Environ. Health Perspect. 1985; 62: 185–191
  • Coal-tars and derived products. IARC Monogr. 1985; 35: 83–159
  • Bertrand J. P., Chau N., Patris A. Mortality due to respiratory cancers in the coke oven plants of the Lorraine coalmining industry (Houillères du Bassin de Lorraine). Br. J. Ind. Med. 1987; 44: 559–565
  • Lloyd J. W. Long-term mortality study of steel workers. V. Respiratory cancer in coke plant workers. J. Occup. Med. 1971; 13(2)53–68
  • Redmond C. K., Ciocco A., Lloyd J. W. Long-term mortality of steelworkers. VI. Mortality from malignant neoplasms among coke oven workers. J. Occup. Med. 1972; 14(8)621–629
  • Reid D., Buck C. Cancer in coking plant workers. Br. J. Ind. Med. 1956; 13: 265–269
  • Pullman A., Pullman B. Electronic structure and carcinogenic activity of aromatic molecules, new developments. Adv. Cancer Res. 1955; 3: 117–169
  • Grover P. L., Hewer A., Sims P. Formation of K-region epoxides as microsomal metabolites of pyrene and benzo(a)pyrene. Biochem. Pharmacol. 1972; 21: 2713–2726
  • Hall M., Grover P. L. Polycyclic aromatic hydrocarbons, metabolism, activation and tumour initiation. Chemical Carcinogenesis and Mutagenesis I. Handbook of Experimental Pharmacology 94/1, C. S. Cooper, P. L. Griver. Springer-Verlag, London 1990; 327–372
  • Yang S. K., Roller P., Fu P. Evidence for a 2,3-epoxide as an intermediate in the microsomal metabolism of benzo(a)pyrene to 3-hydroxybenzo(a)pyrene. Biophys. Res. Commun. 1977; 77: 1176–1182
  • Booth J., Boyland E., Sims P. An enzyme from rat liver catalysing conjugations with glutathione. Biochem. J. 1961; 79: 516–524
  • Combes B., Stakelum G. S. A liver enzyme that conjugates sulfabromophthalein sodium with glutathione. J. Clin. Invest. 1961; 40: 981–988
  • Jakoby W. B., Ketterer B., Mannervik B. Glutathione transferases: nomenclature. Biochem. Pharmacol. 1984; 33: 2539–2540
  • Mannervik B., Jensson H. Binary combinations of four protein sub-units with different catalytic specificities explain the relationship between six basic glutathione S-transferases in rat liver cytosol. J. Biol. Chem. 1982; 257: 9909–9912
  • Chipman J. K., Frost G. S., Hirom P. C. Biliary excretion, systemic availability and reactivity of metabolites following intraportal infusion of ‘3H’-benzo(a)pyrene in the rat. Carcinogenesis 1981; 2: 741–745
  • Renwick A. G., Drasar B. S. Environmental carcinogens and large bowel cancer. Nature 1976; 263: 234–235
  • Nemoto N., Takayama S., Gelboin H. V. Sulphate conjugation of benzo(a)pyrene metabolites and derivatives. Chem. Biol. Interact. 1978; 23: 19–30
  • Autrup H. Separation of water-soluble metabolites of benzo(a)pyrene formed by cultured human colon. Biochem. Pharmacol. 1979; 28: 1727–1730
  • Moore B. P., Cohen G. M. Metabolism of benzo(a)pyrene and its major metabolites to ethyl acetate-soluble and water-soluble metabolites by cultured rodent trachea. Cancer. Res. 1978; 38: 3066–3075
  • Bickers D. R., Mukhtar H. Dermal metabolism of drugs and carcinogens. Prediction of Percutaneous Penetration. Methods, Measurement, Modelling, 2, IBC Technical Services, R. C. Scott, R. H. Guy, J. Hadgraft, H. E. Boddé, 1992; 248–258
  • Pelkonen O., Nebert S. W. Metabolism of polycyclic aromatic hydrocarbons: etiological role in carcinogenesis. Pharmacol. Rev. 1982; 34: 189
  • Mukhtar H., Khan W. A. Cutaneous cytochrome P-450. Drug. Metab. Rev. 1989; 20(2–4)657–673
  • Finnen M. J., Lawrence C. M., Shuster S. Human skin aryl hydrocarbon hydroxylase. Br. J. Dermatol. 1984; 110: 339–342
  • Wiebel F. J., Leutz J. C., Gelboin H. V. Aryl hydrocarbon hydroxylase: a mixed function oxygenase in mouse skin. J. Invest. Dermatol. 1975; 64: 184
  • Chapman P. H., Kersey P., Shuster S. Generalized tissue abnormality of aryl hydrocarbon hydroxylase in psoriasis. Br. Med. J. 1980; 282: 20
  • Chapman P. H., Rawlins M. D., Shuster S. The activity of aryl hydrocarbon hydroxylase in psoriatic skin. Lancet 1979; 1: 297–298
  • Chapman P. H., Rawlins M. D., Shuster S. The activity of AHH in human skin. Br. J. Clin. Pharmacol. 1979; 7: 499
  • Shuster S., Chapman P. H., Rawlins M. D. Psoriasis and cancer. Br. Med. J. 1979; 1: 941
  • Shuster S., Rawlins M. D., Kersey P. J. Aryl hydrocarbon hydroxylase activity in psoriasis. Br. J. Dermatol. 1981; 104: 352
  • Shuster S., Rawlins M. D., Chapman P. H. Decreased epidermal aryl hydrocarbon hydroxylase and localized pustular psoriasis. Br. J. Dermatol. 1980; 103: 23–26
  • Rawlins M. D., Shuster S., Chapman P. H. Drug Metabolism in Skin. Proceedings of the 1st World Conference on Clinical Pharmacology and Therapeutics, P. Turner. Macmillan Ltd., London 1980; 410–414
  • Kersey P. J., Chapman P. H., Rogers S. The inflammatory response to anthralin and its relation to aryl hydrocarbon hydroxylase. Br. J. Dermatol. 1981; 105: 64
  • Chapman P. H., Kersey P. J., Keys B. Generalised tissue abnormality of aryl hydrocarbon hydroxylase in psoriasis. Br. Med. J. 1980; 281: 1315–1316
  • Thomas P. E., Hutton J., Taylor B. A. Genetic relationship between aryl hydrocarbon hydroxylase inducibility and chemical carcinogen induced skin ulceration in mice. Genetics 1973; 74: 655–659
  • MacNicoll A. D., Grover P. L., Sims P. The metabolism of a series of polycyclic hydrocarbons by mouse skin maintained in short-term organ culture. Chem. Biol. Interact. 1980; 29: 169–188
  • Jongeneelen F. J., Anzion R. B. M., Leijdekkers Ch.-M. 1-hydroxypyrene in human urine after exposure to coal tar and a coal tar derived product. Int. Arch. Occup. Environ. Health. 1985; 57: 47–55
  • Jongeneelen F. J., Scheepers P. T. J., Groenendijk A. Airborne concentrations, skin contamination, and urinary metabolite excretion of polycyclic aromatic hydrocarbons among paving workers exposed to coal tar derived road tars. Am. Ind. Hyg. Assoc. J. 1988; 49(12)600–607
  • Jongeneelen F. J., Anzion R. B. M., Scheepers P. T. J. 1-hydroxypyrene in urine as a biological indicator of exposure to polycyclic aromatic hydrocarbons in several work environments. Ann. Occup. Hyg 1988; 52(1)35–43
  • Clonfero E., Zordan M., Venier P. Biological monitoring of human exposure to coal tar. Int. Arch. Occup. Environ. Health. 1989; 61: 363–368
  • VanRooij J. G. M., Bodelier-Bade M., Jongeneelen F. J. Estimation of individual dermal and respiratory uptake of polycyclic aromatic hydrocarbons in 12 coke oven workers. Br. J. Ind. Med. 1993; 50: 623–632
  • Hansen A. M., Poulsen O. M., Menne T. Longitudinal study of excretion of metabolites of polycyclic aromatic hydrocarbons in urine from two psoriatic patients. Acta. Derm. Venereal. (Stockh). 1993; 73: 188–190
  • van Schooten F.-J., Moonen E. J. C., Rhijnburger E. Dermal uptake of polycyclic aromatic hydrocarbons after hair wash with coal-tar shampoo. Lancet 1994; 344: 1505–1506
  • Wheeler L. A., Saperstein M. D., Lowe N. J. Mutagenicity of urine from psoriatic patients undergoing treatment with coal tar and ultraviolet light. J. Invest. Dermatol. 1981; 77: 181–185
  • Cook J. W., Hewett C. L., Hieger I. The isolation of a cancer-producing hydrocarbon from coal tar, Parts I, II, and III. J. Chem. Soc 1933; 395–405
  • Cook J. W., Haslewood A. D., Hewett C. L. Chemical compounds as carcinogenic agents. Am. J. Cancer. 1937; 29(2)219–259
  • Shubik P. Carcinogenesis and acute intoxication with large doses of polycyclic hydrocarbons. Arch. Pathol. 1957; 64: 691–703
  • Shubik P., Pietra G., Porta G. D. Studies of skin carcinogenesis in the Syrian golden hamster. Cancer Res. 1960; 20: 100–105
  • IARC monographs on the evaluation of carcinogenic risks to humans. Overall evaluations of carcinogenicity: an updating of IARC monographs. 1987; 1–42(suppl 7)175–177
  • Stern R. S., Zierler S., Parrish J. A. Skin carcinoma in patients treated with topical tar and artificial ultraviolet radiation. Lancet 1980; 1: 732–733
  • Blum H. F. On the mechanism of cancer induction by ultraviolet radiation. J. Natl. Cancer. Inst. 1950; 11: 463
  • Urbach F., Epstein J. H., Forbes P. D. Ultraviolet carcinogenesis: Experimental, global and genetic aspects, M. A. Pathak, L. C. Harber, M. Seiji, A. Kukita. University of Tokyo Press, Tokyo 1974; 259–283
  • Findlay G. M. Ultraviolet light and skin cancer. Lancet 1928; 2: 1070
  • Maughan W. Z., Muller S. A., Perry H. O. Incidence of skin cancers in patients with atopic dermatitis treated with coal tar. A 25 year follow-up study. J. Am. Acad. Dermatol. 1980; 3(6)612–615
  • Pittelkow M. R., Perry H. O., Muller S. A. Skin cancer in patients with psoriasis treated with coal tar. Arch. Dermatol. 1981; 117: 465–468
  • Jones S. K., Mackie R. M., Hole D. J. Further evidence of the safety of tar in the management of psoriasis. Br. J. Dermatol. 1985; 113: 97–101
  • Schoket B., Hewer A., Grover P. L. Covalent binding of components of coal-tar, creosote and bitumen to the DNA of the skin and lungs of mice following topical application. Carcinogenesis 1988; 9(7)1253–1258
  • Randerath E., Mittal D., Randerath K. Tissue distribution of covalent DNA damage in mice treated dermally with cigarette “tar”: Preference for lung and heart DNA. Carcinogenesis 1988; 9(1)75–80
  • Perera F. P., Hemminki K., Young T. L. Detection of polycyclic aromatic hydrocarbon-DNA adducts in white blood cells of foundry workers. Cancer Res. 1988; 48: 2288–2291
  • Cottini G. B., Mazzone G. B. The effects of 3:4-benzpyrene on human skin. Am. J. Cancer. 1939; 37: 186–195
  • Benzo(a)pyrene. IARC Monogr. 1983; 32: 211–224
  • Sanders C. L., Skinner C., Gelman R. A. Percutaneous absorption of ‘7,10-14C’benzo(a)pyr-ene and ‘7,12-14C’dimethylbenz(a)anthracene in mice. Environ. Res. 1984; 33: 353–360
  • Malaveille C., Bartsch H., Grover P. L. Mutagenicity of non-K-region diols and diolepoxides of benzanthracene and benzo(a)pyrene in S. typhimurium TA 100. Biochem. Biophys. Res. Commun. 1975; 66: 693
  • Wislocki P. G., Lu A. Y. H. Carcinogenicity and mutagenicity of proximate and ultimate carcinogens of polycyclic aromatic hydrocarbons. Polycyclic Aromatic Hydrocarbon Carcinogenesis: Structure-Activity Relationships, S. K. Yang, B. D. Silverman. CRC Press Inc., Boca Raton, FL 1988; Vol I: 1–30
  • Haugen D. A., Peak M. J. Mixtures of polycyclic aromatic compounds inhibit mutagenesis in the Salmonellalmicmsome assay by inhibition of metabolic activation. Mutat. Res. 1983; 116: 257–269
  • IARC Monogr. 1973; 3: 91–136
  • Bock F. G. Species differences in penetration and absorption of chemical carcinogens. NCI Monogr. 1963; 10: 361–375
  • Oesch F., Doehmer J., Friedberg T. Toxicological implications of enzymatic control of reactive metabolites. Hum. Exp. Toxicol. 1990; 9: 171–177
  • Dennis M. J., Massey R. C., McWeeny D. J. Analysis of polycyclic aromatic hydrocarbons in UK total diets. Fd. Chem. Toxicol. 1983; 21(5)569–574
  • Strait L. A., Hrenoff M. K., DeOme K. B. The influence of solvents upon the effectiveness of carcinogenic agents. Cancer Res. 1948; 8: 231–240
  • Bock F. G., Burnham M. The effect of experimental conditions upon the concentration of hydrocarbons in mouse skin after cutaneous application. Cancer Res. 1961; 21: 510–515
  • Crabtree H. G. Influence of solvent on the rate of induction of epithelial skin tumours in mice. J. Pathol. Bacterial. 1940; 51: 299–302

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.